DK0531876T3 - - Google Patents

Info

Publication number
DK0531876T3
DK0531876T3 DK92114987.8T DK92114987T DK0531876T3 DK 0531876 T3 DK0531876 T3 DK 0531876T3 DK 92114987 T DK92114987 T DK 92114987T DK 0531876 T3 DK0531876 T3 DK 0531876T3
Authority
DK
Denmark
Prior art keywords
substituted
pharmaceutically acceptable
imidazoindolizine
unsubstituted phenyl
phenyl
Prior art date
Application number
DK92114987.8T
Other languages
Danish (da)
English (en)
Inventor
Hiroshi Narita
Yasushi Honma
Yasuo Sekine
Sumihiro Nomura
Kazuaki Naito
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of DK0531876T3 publication Critical patent/DK0531876T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK92114987.8T 1991-09-10 1992-09-02 DK0531876T3 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30856091 1991-09-10
JP5304492 1992-01-27

Publications (1)

Publication Number Publication Date
DK0531876T3 true DK0531876T3 (ja) 1997-02-17

Family

ID=26393753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92114987.8T DK0531876T3 (ja) 1991-09-10 1992-09-02

Country Status (16)

Country Link
US (1) US5268377A (ja)
EP (1) EP0531876B1 (ja)
JP (1) JP2590797B2 (ja)
KR (1) KR0168457B1 (ja)
AT (1) ATE146474T1 (ja)
AU (1) AU644539B2 (ja)
CA (1) CA2077420C (ja)
DE (1) DE69216013T2 (ja)
DK (1) DK0531876T3 (ja)
ES (1) ES2098403T3 (ja)
FI (1) FI98369C (ja)
GR (1) GR3022106T3 (ja)
ID (1) ID902B (ja)
IL (1) IL103021A (ja)
MY (1) MY129927A (ja)
SG (1) SG42962A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271576A (ja) * 1993-03-19 1994-09-27 Upjohn Co:The イミダゾール誘導体の製法
FR2712592B1 (fr) * 1993-11-17 1995-12-22 Adir Nouveaux dérivés tricycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
AU2017289974B2 (en) 2016-06-29 2021-08-12 Bristol-Myers Squibb Company Biarylmethyl heterocycles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1047148A1 (ru) * 1981-03-30 1986-12-23 Институт физико-органической химии и углехимии АН УССР Бензилиденпроизводные имидазо-[4,5-L]-индолизинов,обладающие бактериостатической и фунгистатической активностью
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
US4816463A (en) * 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
ATE146474T1 (de) 1997-01-15
FI924043A0 (fi) 1992-09-10
KR0168457B1 (ko) 1999-01-15
ID902B (id) 1996-09-09
FI98369B (fi) 1997-02-28
GR3022106T3 (en) 1997-03-31
JP2590797B2 (ja) 1997-03-12
AU644539B2 (en) 1993-12-09
DE69216013T2 (de) 1997-05-07
DE69216013D1 (de) 1997-01-30
CA2077420C (en) 1998-08-25
AU2205692A (en) 1993-03-11
IL103021A0 (en) 1993-02-21
EP0531876A2 (en) 1993-03-17
CA2077420A1 (en) 1993-03-11
SG42962A1 (en) 1997-10-17
FI98369C (fi) 1997-06-10
EP0531876A3 (en) 1993-05-05
MY129927A (en) 2007-05-31
KR930006024A (ko) 1993-04-20
ES2098403T3 (es) 1997-05-01
EP0531876B1 (en) 1996-12-18
FI924043A (fi) 1993-03-11
JPH05279365A (ja) 1993-10-26
IL103021A (en) 1996-10-16
US5268377A (en) 1993-12-07

Similar Documents

Publication Publication Date Title
NZ514873A (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
GB9625045D0 (en) Parasiticidal compounds
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
HUT52058A (en) Process for producing n-substituted nicotinamide derivatives
HK1004483A1 (en) Heterobicyclic derivatives
DK0531876T3 (ja)
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NZ514662A (en) Amine derivatives
EP0725074A3 (en) Compounds for use, therefore, intermediates for the preparation of androst-3,5-diene-3-carboxy derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
AU6948091A (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
CS743389A3 (en) Amino(methyl)phenyl derivatives, process for their preparation and use
CA2256609A1 (en) 5-aroylpyrrol-2-ylmethylarene derivatives as inhibitors of prostaglandin g/h synthase
AU3402701A (en) TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
HK1005732A1 (en) Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
GR3021529T3 (en) Pyrrolidine derivatives
WO2001004122A3 (en) New 2,3-benzodiazepine derivatives
AU1625795A (en) Imidazopyridine derivatives and process for preparing the same
TW327636B (en) Heterocyclic ring-fused pyrimidine derivatives
ES2076865A1 (es) Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).
GEP20012417B (en) Indole Derivatives, Their Salts, Solvates and Physiologically Functional Derivatives, Method for Its Production, Therapeutic Compounds and Method for Their Preparation